1 year return (CAGR)
80.44%
Tourmaline Bio Inc. Exchange (NASDAQ, USD)
TRML
-
0.00 (0.00%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.23B
Price/Sales
-
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
-
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
No data
Stock price data
| Open | 47.98 |
| Daily high | 47.98 |
| Daily low | 47.98 |
| Daily Volume | 0K |
| 1y analyst estimate | 48.00 |
| Beta | 1.58 |
| EPS (TTM) | - |
| Dividend per share | 0.00 |
| Ex-div date | 20 Oct 2023 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| TRML | S&P500 | |
| Current price drop from All-time high | -74.22% | -1.10% |
| Highest price drop | -93.50% | -56.47% |
| Date of highest drop | 10 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -87.43% | -10.68% |
| Avg time to new high | - | 12 days |
| Max time to new high | 265 days | 1805 days |
News
No items found